120 related articles for article (PubMed ID: 27883295)
1. Identification of novel SNPs associated with risk and prognosis in patients with castration-resistant prostate cancer.
Sissung TM; Deeken J; Leibrand CR; Price DK; Ehrlich S; Steinberg SM; Liewehr DJ; Dahut W; Figg WD
Pharmacogenomics; 2016 Dec; 17(18):1979-1986. PubMed ID: 27883295
[TBL] [Abstract][Full Text] [Related]
2. Germline genetic variation in JAK2 as a prognostic marker in castration-resistant prostate cancer.
Zhang BY; Riska SM; Mahoney DW; Costello BA; Kohli R; Quevedo JF; Cerhan JR; Kohli M
BJU Int; 2017 Mar; 119(3):489-495. PubMed ID: 27410686
[TBL] [Abstract][Full Text] [Related]
3. Association of genetic variation of the six gene prognostic model for castration-resistant prostate cancer with survival.
Xie W; Stopsack KH; Drouin SJ; Fu H; Pomerantz MM; Mucci LA; Lee GM; Kantoff PW
Prostate; 2019 Jan; 79(1):73-80. PubMed ID: 30141208
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic markers in circulating cell-free DNA as prognostic markers for survival of castration-resistant prostate cancer patients.
Hendriks RJ; Dijkstra S; Smit FP; Vandersmissen J; Van de Voorde H; Mulders PFA; van Oort IM; Van Criekinge W; Schalken JA
Prostate; 2018 Apr; 78(5):336-342. PubMed ID: 29330943
[TBL] [Abstract][Full Text] [Related]
5. Factors predicting progression to castrate-resistant prostate cancer in patients with advanced prostate cancer receiving long-term androgen-deprivation therapy.
de la Taille A; Martínez-Piñeiro L; Cabri P; Houchard A; Schalken J;
BJU Int; 2017 Jan; 119(1):74-81. PubMed ID: 26919403
[TBL] [Abstract][Full Text] [Related]
6. SRD5A gene polymorphism in Japanese men predicts prognosis of metastatic prostate cancer with androgen-deprivation therapy.
Shiota M; Fujimoto N; Yokomizo A; Takeuchi A; Itsumi M; Inokuchi J; Tatsugami K; Uchiumi T; Naito S
Eur J Cancer; 2015 Sep; 51(14):1962-9. PubMed ID: 26169017
[TBL] [Abstract][Full Text] [Related]
7. Common Genetic Variation in CYP17A1 and Response to Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer.
Binder M; Zhang BY; Hillman DW; Kohli R; Kohli T; Lee A; Kohli M
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27409606
[TBL] [Abstract][Full Text] [Related]
8. CYP17A1 polymorphisms and clinical outcome of castration-resistant prostate cancer patients treated with abiraterone.
Salvi S; Casadio V; Burgio SL; Conteduca V; Rossi L; Menna C; Carretta E; Costantini M; Zoli W; De Giorgi U
Int J Biol Markers; 2016 Jul; 31(3):e264-9. PubMed ID: 26954071
[TBL] [Abstract][Full Text] [Related]
9. Variations of ABCB4 and ABCB11 genes are associated with primary intrahepatic stones.
Pan S; Li X; Jiang P; Jiang Y; Shuai L; He Y; Li Z
Mol Med Rep; 2015 Jan; 11(1):434-46. PubMed ID: 25323205
[TBL] [Abstract][Full Text] [Related]
10. Shifting paradigms in the estimation of survival for castration-resistant prostate cancer: A tertiary academic center experience.
Afshar M; Evison F; James ND; Patel P
Urol Oncol; 2015 Aug; 33(8):338.e1-7. PubMed ID: 26059077
[TBL] [Abstract][Full Text] [Related]
11. Relationship between glutathione S-transferase P1 (GSTP1), X-ray repair cross complementing group 1 (XRCC1) and 5,10-methylenetetrahydrofolate reductase (5,10-MTHFR) gene polymorphisms and response to chemotherapy in advanced gastric cancer.
Ji M; Xu B; Jiang JT; Wu J; Li XD; Zhao WQ; Zhang HY; Zhou WJ; Wu CP
Onkologie; 2013; 36(6):335-40. PubMed ID: 23774147
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific antigen kinetic profiles during androgen deprivation therapy as prognostic factors in castration-resistant prostate cancer.
Kim M; Lee J; Jeong CW; Ku JH; Kim HH; Kwak C
Urol Oncol; 2015 May; 33(5):203.e1-9. PubMed ID: 25726498
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic association between GSTP1 genetic polymorphism and febrile neutropenia in Japanese patients with early breast cancer.
Sugishita M; Imai T; Kikumori T; Mitsuma A; Shimokata T; Shibata T; Morita S; Inada-Inoue M; Sawaki M; Hasegawa Y; Ando Y
Breast Cancer; 2016 Mar; 23(2):195-201. PubMed ID: 25008867
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene.
Wasmuth HE; Glantz A; Keppeler H; Simon E; Bartz C; Rath W; Mattsson LA; Marschall HU; Lammert F
Gut; 2007 Feb; 56(2):265-70. PubMed ID: 16891356
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer.
Xu Z; Zhu H; Luk JM; Wu D; Gu D; Gong W; Tan Y; Zhou J; Tang J; Zhang Z; Wang M; Chen J
Cancer; 2012 Nov; 118(22):5489-96. PubMed ID: 22517484
[TBL] [Abstract][Full Text] [Related]
16. A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease.
Iwata R; Baur K; Stieger B; Mertens JC; Daly AK; Frei P; Braun J; Vergopoulos A; Stickel F; Sabrane K; Martin IV; Schmitt J; Goetze O; Day CP; Müllhaupt B; Geier A;
Clin Sci (Lond); 2011 Apr; 120(7):287-96. PubMed ID: 20883210
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the Lith1 candidate genes ABCB11 and LXRA in human gallstone disease.
Schafmayer C; Tepel J; Franke A; Buch S; Lieb S; Seeger M; Lammert F; Kremer B; Fölsch UR; Fändrich F; Schreiber S; Hampe J
Hepatology; 2006 Sep; 44(3):650-7. PubMed ID: 16941683
[TBL] [Abstract][Full Text] [Related]
18. XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro), and GSTP1 (Ile105Val) polymorphisms in prognosis of cutaneous melanoma.
Gomez GV; de Oliveira C; Rinck-Junior JA; de Moraes AM; Lourenço GJ; Lima CS
Tumour Biol; 2016 Mar; 37(3):3163-71. PubMed ID: 26427666
[TBL] [Abstract][Full Text] [Related]
19. Predictive potential role of glutathione S-transferases polymorphisms in response to chemotherapy and breast cancer prognosis.
Yuan P; Yuan L; Xu BL; Wang CZ; Yang HZ; Li Y
Genet Mol Res; 2015 Dec; 14(4):16675-81. PubMed ID: 26681014
[TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase P1 gene rs4147581 polymorphism predicts overall survival of patients with hepatocellular carcinoma: evidence from an enlarged study.
Wang Z; Qu K; Niu W; Lin T; Xu X; Huang Z; Liu S; Liu S; Chang H; Liu Y; Dong X; Liu C; Zhang Y
Tumour Biol; 2016 Jan; 37(1):943-52. PubMed ID: 26260272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
